AIA
IBB icon

Ally Invest Advisors’s iShares Biotechnology ETF IBB Stock Holding History

Ally Invest Advisors’s Portfolio IBB Stock Details IBB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$299K Sell
1,571
-100
-6% -$17.2K 0.02% 68
2026
Q1 		$282K Sell
1,671
-91
-5% -$15.6K 0.02% 70
2025
Q4 		$297K Sell
1,762
-228
-11% -$37K 0.02% 69
2025
Q3 		$287K Buy
1,990
+52
+3% +$7.1K 0.02% 67
2025
Q2 		$245K Buy
1,938
+338
+21% +$41.5K 0.02% 71
2025
Q1 		$205K Buy
1,600
+85
+6% +$11.5K 0.02% 70
2024
Q4 		$200K Buy
1,515
+76
+5% +$10.7K 0.02% 67
2024
Q3 		$210K Buy
+1,439
New +$208K 0.02% 67

Other funds holding IBB

Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $424B AUM 22.9% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
CB
Commerce Bank Kansas City, Missouri $22.8B AUM 28.56% 1-Year Est. Return

Ally Invest Advisors's IBB Position: Q2 2026 in Review

Ally Invest Advisors reduced its iShares Biotechnology ETF (IBB) stake by 6% in Q2 2026, selling an estimated $17.2K and leaving 1,571 shares worth $299K. The position accounts for 0.02% of the portfolio, ranked #68.

Ally Invest Advisors first reported a position in IBB in Q3 2024 and has held it in 8 quarters since. 960 funds tracked by Wall St. Rank hold IBB as of Q2 2026.

  • Ally Invest Advisors held 1,571 shares of iShares Biotechnology ETF worth $299K as of Q2 2026.
  • Ally Invest Advisors sold 100 iShares Biotechnology ETF shares in Q2 2026, an estimated $17.2K.
  • iShares Biotechnology ETF made up 0.02% of Ally Invest Advisors's portfolio in Q2 2026, its #68 holding.
  • Ally Invest Advisors first reported a position in iShares Biotechnology ETF in Q3 2024 and has held it in 8 quarters since.
  • 960 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2026.

Based on Ally Invest Advisors's 13F filing for Q2 2026, filed 13 Aug 2026.